Operating Margin in % of Immuneering Corp from 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Immuneering Corp quarterly/annual Operating Margin history and change rate from 2020 to Q3 2023.
  • Immuneering Corp Operating Margin for the quarter ending 30 Sep 2023 was -12.3M %, a 127560% decline year-over-year.
  • Immuneering Corp annual Operating Margin for 2022 was -16.3K %, a 902% decline from 2021.
  • Immuneering Corp annual Operating Margin for 2021 was -1.63K %, a 120% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Immuneering Corp Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -12.3M -12.3M -127560% 01 Jul 2023 30 Sep 2023
Q2 2023 -143K -138K -2961% 01 Apr 2023 30 Jun 2023
Q1 2023 -40.1K -37.5K -1399% 01 Jan 2023 31 Mar 2023
Q4 2022 -16.3K -14.7K -902% 01 Oct 2022 31 Dec 2022
Q3 2022 -9.66K 01 Jul 2022 30 Sep 2022
Q2 2022 -4.66K 01 Apr 2022 30 Jun 2022
Q1 2022 -2.68K 01 Jan 2022 31 Mar 2022
Q4 2021 -1.63K 01 Oct 2021 31 Dec 2021

Immuneering Corp Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2022 -16.3K -14.7K -902% 01 Jan 2022 31 Dec 2022
2021 -1.63K -890 -120% 01 Jan 2021 31 Dec 2021
2020 -739 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.